SOME CLINICAL, HISTOPATHOLOGICAL AND IMMUNOHISTOCHEMICAL EXPRESSION IN INVASIVE LOBULAR CARCINOMA OF THE BREAST

Khoa Phạm Hồng, Tâm Đinh Hữu

Main Article Content

Abstract

Objective: To improve the quality of diagnosis, treatment, and prognosis for breast cancer. Subjects and Methods: We conducted a retrospective descriptive study on 167 invasive lobular carcinoma (ILC) patients who underwent a mastectomy at K Hospital from January 2019 to July 2023. Results: The mean age of the study group was 52,78 ± 11,64 years. Mean tumor size was 2,81±1,51cm. In the study, the majority of patients with ILC were unifocal with 154 cases accounting for 92.2%; the rate of multifocal was 7.8%. ER-positive, PR-positive and HER2-positive rate were 88,0%, 79,0%, 12%, respectively; Ki67 more than 20% made up 45,5%. Luminal A and luminal B with HER2(-) subtypes accounted for the highest rate with 40,1% and 41,9% respectively. The Luminal B with HER2(+), HER2-enriched, Tripple negative breast cancer subtype accounted for a small percentage, there were 10 cases and equivalent to 6% for each of these 3 subtypes. Conclusion: The mean age of the group was 52,78 ± 11,64 years. Mean tumor size was 2,81±1,51cm. In the study, the majority of patients with ILC were unifocal accounting for 92.2%; the rate of multifocal was 7.8%. Luminal A and luminal B with HER2(-) were the two most common subtypes in ILC with the rate of 40,1% and 41,9% respectively.

Article Details

References

1. Tan PH, Ellis I, Allison K, et al. The 2019 World Health Organization classification of tumours of the breast. Histopathology. Aug 2020;77(2):181-185. doi:10.1111/his.14091
2. Porter AJ, Evans EB, Foxcroft LM, Simpson PT, Lakhani SR. Mammographic and ultrasound features of invasive lobular carcinoma of the breast. Journal of medical imaging and radiation oncology. Feb 2014;58(1):1-10. doi:10.1111/ 1754-9485.12080
3. Güven HE, Kültüroğlu MO, Gülçelik MA, Özaslan C. Sentinel Lymph Node Metastasis in Invasive Lobular Carcinoma of the Breast. European journal of breast health. Apr 1 2018;14(2):117-120. doi:10.5152/ ejbh. 2018. 3712
4. Bozkurt E, Kaya C, Ucak R, Demircioglu MK, Guven O, Mihmanli M. Invasive lobular carcinoma of the breast: clinicopathological features and patient outcomes. Annali italiani di chirurgia. 2021;92:494-499.
5. Yang LY, Yang LP, Zhu B. Clinicopathological characteristics and survival outcomes of invasive lobular carcinoma in different races. Oncotarget. Sep 26 2017;8(43):74287-74298. doi:10.18632/ oncotarget. 19396
6. Da Ros L, Moretti A, Querzoli P, et al. HER2-Positive Lobular Versus Ductal Carcinoma of the Breast: Pattern of First Recurrence and Molecular Insights. Clinical breast cancer. Oct 2018;18(5): e1133-e1139. doi:10.1016/j.clbc.2018.04.006
7. van't Veer P, Kok FJ, Hermus RJ, Sturmans F. Alcohol dose, frequency and age at first exposure in relation to the risk of breast cancer. International journal of epidemiology. Sep 1989;18(3):511-7. doi: 10.1093/ ije/18.3.511
8. Li CI, Malone KE, Daling JR. Differences in breast cancer hormone receptor status and histology by race and ethnicity among women 50 years of age and older. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Jul 2002;11(7):601-7.